NTLA
Price
$8.52
Change
-$0.03 (-0.35%)
Updated
Nov 26 closing price
Capitalization
986.87M
83 days until earnings call
Intraday BUY SELL Signals
PLRX
Price
$1.58
Change
+$0.01 (+0.64%)
Updated
Nov 26 closing price
Capitalization
97.09M
95 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NTLA vs PLRX

Header iconNTLA vs PLRX Comparison
Open Charts NTLA vs PLRXBanner chart's image
Intellia Therapeutics
Price$8.52
Change-$0.03 (-0.35%)
Volume$3.14M
Capitalization986.87M
Pliant Therapeutics
Price$1.58
Change+$0.01 (+0.64%)
Volume$969.65K
Capitalization97.09M
NTLA vs PLRX Comparison Chart in %
NTLA
Daily Signal:
Gain/Loss:
PLRX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
NTLA vs. PLRX commentary
Nov 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTLA is a StrongBuy and PLRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 28, 2025
Stock price -- (NTLA: $8.52 vs. PLRX: $1.58)
Brand notoriety: NTLA and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NTLA: 36% vs. PLRX: 123%
Market capitalization -- NTLA: $986.87M vs. PLRX: $97.09M
NTLA [@Biotechnology] is valued at $986.87M. PLRX’s [@Biotechnology] market capitalization is $97.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $109.65B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTLA’s FA Score shows that 1 FA rating(s) are green whilePLRX’s FA Score has 0 green FA rating(s).

  • NTLA’s FA Score: 1 green, 4 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, NTLA is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTLA’s TA Score shows that 5 TA indicator(s) are bullish while PLRX’s TA Score has 3 bullish TA indicator(s).

  • NTLA’s TA Score: 5 bullish, 5 bearish.
  • PLRX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, NTLA is a better buy in the short-term than PLRX.

Price Growth

NTLA (@Biotechnology) experienced а +3.40% price change this week, while PLRX (@Biotechnology) price change was +5.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.76%. For the same industry, the average monthly price growth was -1.24%, and the average quarterly price growth was +71.95%.

Reported Earning Dates

NTLA is expected to report earnings on Feb 19, 2026.

PLRX is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+4.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($987M) has a higher market cap than PLRX($97.1M). NTLA YTD gains are higher at: -26.930 vs. PLRX (-88.003). PLRX has higher annual earnings (EBITDA): -201.76M vs. NTLA (-501.87M). NTLA has more cash in the bank: 460M vs. PLRX (263M). PLRX has less debt than NTLA: PLRX (60.4M) vs NTLA (103M). NTLA has higher revenues than PLRX: NTLA (52.9M) vs PLRX (0).
NTLAPLRXNTLA / PLRX
Capitalization987M97.1M1,016%
EBITDA-501.87M-201.76M249%
Gain YTD-26.930-88.00331%
P/E RatioN/AN/A-
Revenue52.9M0-
Total Cash460M263M175%
Total Debt103M60.4M171%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NTLAPLRX
RSI
ODDS (%)
Bullish Trend 3 days ago
85%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 17 days ago
77%
Declines
ODDS (%)
Bearish Trend 9 days ago
88%
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
NTLA
Daily Signal:
Gain/Loss:
PLRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IIJIY36.991.45
+4.09%
Internet Initiative Japan, Inc.
FMANF0.13N/A
+2.26%
Freeman Gold Corp.
GSFD0.08N/A
N/A
Global Seafood Technologies, Inc.
TRUHF0.14N/A
N/A
Truly International Holdings Ltd.
WLMIF2.31-0.19
-7.68%
Wilmar International, Ltd.